Quarterly Results Results Snapshot
YoYQoQ
Figures in Cr
Consolidate Quarterly Results
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Net Sales
175.19
170.95
161.76
137.99
114.21
103.02
100.63
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
175.19
170.95
161.76
137.99
114.21
103.02
100.63
Raw Material Cost
27.05
36.96
46.09
29.38
20.94
23.10
28.08
Purchase of Finished goods
35.71
37.87
11.00
27.55
29.06
22.13
22.00
(Increase) / Decrease In Stocks
3.46
-7.81
-0.01
4.43
7.46
-4.53
-2.16
Employee Cost
30.32
30.66
29.63
21.65
14.63
19.01
14.70
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
31.16
22.87
25.54
20.82
22.68
17.62
14.74
Total Expenditure (Excl Depreciation)
127.70
120.55
112.25
103.83
94.77
77.33
77.36
Operating Profit (PBDIT) excl Other Income
47.49
50.40
49.51
34.16
19.44
25.69
23.27
Other Income
17.67
7.39
5.41
3.36
11.77
5.16
1.86
Operating Profit (PBDIT)
65.16
57.79
54.92
37.52
31.21
30.85
25.13
Interest
8.46
5.33
6.19
5.04
5.30
6.16
5.27
Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
56.70
52.46
48.73
32.48
25.91
24.69
19.86
Depreciation
9.30
7.86
8.09
5.99
5.23
4.20
3.89
Profit Before Tax
47.40
44.60
40.64
26.49
20.68
20.49
15.97
Tax
10.73
11.02
10.52
5.31
2.71
4.06
2.90
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
36.67
33.58
30.12
21.18
17.97
16.43
13.07
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
36.67
33.58
30.12
21.18
17.97
16.43
13.07
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
5.06
1.92
-2.26
1.45
0.14
-0.75
0.23
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
31.61
31.66
32.38
19.73
17.83
17.18
12.84
Equity Capital
46.05
46.05
46.05
46.05
46.05
46.05
33.27
Face Value
10.0
10.0
10.0
10.0
10.0
10.0
10.0
Reserves
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Earnings per share (EPS)
6.86
6.88
7.03
4.28
3.87
3.73
3.86
Diluted Earnings per share
7.96
7.29
6.54
4.6
3.81
5.04
3.92
Operating Profit Margin (Excl OI)
27.11%
29.48%
32.28%
26.22%
17.02%
24.94%
23.68%
Gross Profit Margin
32.36%
30.69%
31.77%
24.93%
22.69%
23.97%
20.21%
PAT Margin
20.93%
19.64%
19.64%
16.25%
15.73%
15.95%
13.3%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Mar 2026 is 2.48% vs 5.68% in Dec 2025
Consolidate Net Profit
QoQ Growth in quarter ended Mar 2026 is -0.16% vs -2.22% in Dec 2025
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Mar 2026 is -5.77% vs 1.80% in Dec 2025
Interest
QoQ Growth in quarter ended Mar 2026 is 58.72% vs -13.89% in Dec 2025
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Mar 2026 has fallen from Dec 2025
Compare Quarterly Results Of Senores Pharma. With
Figures in Cr
Consolidate Quarterly Results
Change(INR)
Change(%)
Net Sales
175.19
1,853.22
-1,678.03
-90.55%
Other Operating Income
0.00
0.00
0.00
Total Operating income
175.19
1,853.22
-1,678.03
-90.55%
Raw Material Cost
27.05
5.16
21.89
424.22%
Purchase of Finished goods
35.71
0.00
35.71
(Increase) / Decrease In Stocks
3.46
0.00
3.46
Employee Cost
30.32
26.02
4.30
16.53%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
2.84
-2.84
-100.00%
Selling and Distribution Expenses
0.00
29.30
-29.30
-100.00%
Other Expenses
31.16
16.70
14.46
86.59%
Total Expenditure (Excl Depreciation)
127.70
80.02
47.68
59.59%
Operating Profit (PBDIT) excl Other Income
47.49
1,773.20
-1,725.71
-97.32%
Other Income
17.67
1.80
15.87
881.67%
Operating Profit (PBDIT)
65.16
1,775.00
-1,709.84
-96.33%
Interest
8.46
11.64
-3.18
-27.32%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
56.70
1,763.36
-1,706.66
-96.78%
Depreciation
9.30
2.40
6.90
287.50%
Profit Before Tax
47.40
1,760.96
-1,713.56
-97.31%
Tax
10.73
-0.38
11.11
2,923.68%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
36.67
1,761.34
-1,724.67
-97.92%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
36.67
1,761.34
-1,724.67
-97.92%
Share in Profit of Associates
0.00
0.00
0.00
Minority Interest
5.06
0.00
5.06
Other related items
0.00
0.00
0.00
Consolidated Net Profit
31.61
1,761.34
-1,729.73
-98.21%
Equity Capital
46.05
32.45
13.60
41.91%
Face Value
10.00
1.00
0.00
Reserves
0.00
0.00
0.00
Earnings per share (EPS)
6.86
54.28
-47.42
-87.36%
Diluted Earnings per share
7.96
54.27
-46.31
-85.33%
Operating Profit Margin (Excl OI)
27.11%
13,433.33%
0.00
-13,406.22%
Gross Profit Margin
32.36%
13,358.79%
0.00
-13,326.43%
PAT Margin
20.93%
13,343.48%
0.00
-13,322.55%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Quarterly - Net Sales
Net Sales 175.19 Cr
in Mar 2026Figures in Cr
QoQ Growth in quarter ended Mar 2026 is 2.48% vs 5.68% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 53.39% vs 11.49% in Mar 2025
Quarterly - Consolidate Net Profit
Consolidate Net Profit 31.61 Cr
in Mar 2026Figures in Cr
QoQ Growth in quarter ended Mar 2026 is -0.16% vs -2.22% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 77.29% vs 11.86% in Mar 2025
Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 47.49 Cr
in Mar 2026Figures in Cr
QoQ Growth in quarter ended Mar 2026 is -5.77% vs 1.80% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 144.29% vs -13.18% in Mar 2025
Quarterly - Interest
Interest 8.46 Cr
in Mar 2026Figures in Cr
QoQ Growth in quarter ended Mar 2026 is 58.72% vs -13.89% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 59.62% vs 74.92% in Mar 2025
Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 27.11%
in Mar 2026Figures in %
QoQ Growth in quarter ended Mar 2026 has fallen from Dec 2025
YoY Growth in quarter ended Mar 2026 has improved from Mar 2025
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
